PLSE - CIK 0001625101
Pulse Biosciences, Inc. has filed 616 documents with the SEC between 2014 and 2026. The most frequent type is insider trade (187 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Company correspondence | CORRESP | 2016-05-10 | - |
| Company correspondence | CORRESP | 2016-05-10 | - |
| Company correspondence | CORRESP | 2016-05-10 | - |
| S-1/A | - | 2016-05-03 | - |
| Free writing prospectus | FWP | 2016-04-19 | - |
| SEC correspondence | UPLOAD | 2016-04-18 | - |
| 8-A12B | - | 2016-04-15 | - |
| Free writing prospectus | FWP | 2016-03-28 | - |
| Company correspondence | CORRESP | 2016-03-28 | - |
| S-1/A | - | 2016-03-28 | - |
| SEC correspondence | UPLOAD | 2016-03-22 | - |
| Company correspondence | CORRESP | 2016-03-07 | - |
| S-1/A | - | 2016-03-07 | - |
| SEC correspondence | UPLOAD | 2016-01-19 | - |
| IPO registration | S-1 | 2015-12-22 | - |
| D | - | 2014-11-13 | - |